(Q36646153)

15 August 2017

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2 (English)

1 reference

15 August 2017

1 reference

Becker JC

1

1 reference

15 August 2017

Terheyden P

2

1 reference

15 August 2017

Kämpgen E

3

1 reference

15 August 2017

Wagner S

4

1 reference

15 August 2017

Neumann C

5

1 reference

15 August 2017

Schadendorf D

6

1 reference

15 August 2017

Steinmann A

7

1 reference

15 August 2017

Wittenberg G

8

1 reference

15 August 2017

Lieb W

9

1 reference

15 August 2017

Bröcker EB

10

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

87

1 reference

15 August 2017

8

1 reference

15 August 2017

840-845

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600521

15 August 2017

0 references

cites work

Histamine: a novel approach to cancer immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Uveal melanoma: natural history and treatment options for metastatic disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Immunotherapy of uveal melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

HLA expression in a primary uveal melanoma, its cell line, and four of its metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Diagnosis and treatment of uveal melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Posterior uveal melanoma. The Swedish perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Screening for metastatic malignant melanoma of the uvea revisited.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Management of uveal melanoma. A continuing dilemma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

The effects of stress in normal and adrenalectomized mice

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Therapy of metastatic malignant uveal melanoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376169

Interleukin-2 therapy for metastatic uveal melanoma

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600521

Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600521

Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma

21 January 2018

1 reference

12 December 2020

Survival of patients with metastases from uveal melanoma

1 reference

12 December 2020

Prognosis and treatment of disseminated uveal melanoma

1 reference

12 December 2020

Inverse correlation between expression of HLA-B and c-myc in uveal melanoma

1 reference

12 December 2020

Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy

1 reference

12 December 2020

BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy

1 reference

12 December 2020

Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity

1 reference

12 December 2020

The ex vivo chemosensitivity profile of choroidal melanoma

1 reference

12 December 2020

Fotemustine and interferon alpha2b in metastatic malignant melanoma

1 reference

12 December 2020

Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy

1 reference

12 December 2020

The treatment of metastatic uveal melanoma

1 reference

12 December 2020

[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature]

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600521

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

12373596

1 reference